↓ Skip to main content

Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register

Overview of attention for article published in Annals of the Rheumatic Diseases, May 2008
Altmetric Badge

Mentioned by

twitter
1 X user
f1000
1 research highlight platform

Citations

dimensions_citation
217 Dimensions

Readers on

mendeley
79 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register
Published in
Annals of the Rheumatic Diseases, May 2008
DOI 10.1136/ard.2007.085852
Pubmed ID
Authors

J Askling, E Baecklund, F Granath, P Geborek, M Fored, C Backlin, L Bertilsson, L Cöster, L T Jacobsson, S Lindblad, J Lysholm, S Rantapää-Dahlqvist, T Saxne, R van Vollenhoven, L Klareskog, N Feltelius

Abstract

Tumour necrosis factor (TNF) antagonists have proved effective as treatment against rheumatoid arthritis (RA), but the unresolved issue of whether the use of anti-TNF therapy increases the already elevated risk of lymphoma in RA remains a concern.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 79 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 2 3%
Germany 1 1%
Norway 1 1%
United Kingdom 1 1%
Brazil 1 1%
Denmark 1 1%
United States 1 1%
Unknown 71 90%

Demographic breakdown

Readers by professional status Count As %
Researcher 16 20%
Other 13 16%
Student > Ph. D. Student 9 11%
Student > Doctoral Student 6 8%
Student > Bachelor 6 8%
Other 22 28%
Unknown 7 9%
Readers by discipline Count As %
Medicine and Dentistry 48 61%
Agricultural and Biological Sciences 10 13%
Pharmacology, Toxicology and Pharmaceutical Science 4 5%
Biochemistry, Genetics and Molecular Biology 1 1%
Psychology 1 1%
Other 3 4%
Unknown 12 15%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 August 2016.
All research outputs
#14,134,869
of 22,649,029 outputs
Outputs from Annals of the Rheumatic Diseases
#5,459
of 7,188 outputs
Outputs of similar age
#65,397
of 78,698 outputs
Outputs of similar age from Annals of the Rheumatic Diseases
#35
of 38 outputs
Altmetric has tracked 22,649,029 research outputs across all sources so far. This one is in the 35th percentile – i.e., 35% of other outputs scored the same or lower than it.
So far Altmetric has tracked 7,188 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.8. This one is in the 22nd percentile – i.e., 22% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 78,698 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 16th percentile – i.e., 16% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 38 others from the same source and published within six weeks on either side of this one. This one is in the 7th percentile – i.e., 7% of its contemporaries scored the same or lower than it.